GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC (XPAE:PHARMACARE) » Definitions » Scaled Net Operating Assets

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Scaled Net Operating Assets : 0.11 (As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's operating assets for the quarter that ended in Dec. 2021 was $71.37 Mil. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's operating liabilities for the quarter that ended in Dec. 2021 was $63.55 Mil. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Total Assets for the quarter that ended in Sep. 2021 was $70.21 Mil. Therefore, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2021 was 0.11.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Scaled Net Operating Assets Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.74 1.04 0.17 0.21 0.12

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.78 0.23 0.66 0.82 0.11

Competitive Comparison of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets falls into.



Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2021 )
=(Operating Assets (A: Dec. 2021 )-Operating Liabilities (A: Dec. 2021 ))/Total Assets (A: Dec. 2020 )
=(71.368-63.553)/64.657
=0.12

where

Operating Assets(A: Dec. 2021 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=72.316 - 0.948
=71.368

Operating Liabilities(A: Dec. 2021 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=72.316 - 1.667 - 7.096
=63.553

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2021 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2021 )
=(Operating Assets (Q: Dec. 2021 )-Operating Liabilities (Q: Dec. 2021 ))/Total Assets (Q: Sep. 2021 )
=(71.368-63.553)/70.208
=0.11

where

Operating Assets(Q: Dec. 2021 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=72.316 - 0.948
=71.368

Operating Liabilities(Q: Dec. 2021 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=72.316 - 1.667 - 7.096
=63.553

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 677, Ramallah, PSE
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC is engaged in the manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Headlines

No Headlines